Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: A simulation study

Experimental Physiology

Volumn 97, Issue 1, 2012, Pages 155-169

  Wu, Bo ^a,b   Wang, Longhui ^a,b   Liu, Qian ^a,b   Luo, Qingming ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TROPONIN I;

ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ENERGY CONSUMPTION; ENERGY METABOLISM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FATTY ACID OXIDATION; GENE MUTATION; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART ELECTROPHYSIOLOGY; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HUMAN; HUMAN CELL; METABOLIC REGULATION; MYOFILAMENT; PATHOGENESIS; SIMULATION; STEADY STATE;

EID: 84355162044     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.059956     Document Type: Article

References (53)

1. Allard MF, Henning SL, Wambolt RB, Granleese SR, English DR & Lopaschuk GD (1997). Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation 96, 676-682.
2. Allard MF, Schonekess BO, Henning SL, English DR & Lopaschuk GD (1994). Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol Heart Circ Physiol 267, H742-H750.
3. Ashrafian H, Redwood C, Blair E & Watkins H (2003). Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet 19, 263-268.
4. Berlin JR, Bassani JW & Bers DM (1994). Intrinsic cytosolic calcium buffering properties of single rat cardiac myocytes. Biophys J 67, 1775-1787.
5. Bishop SP & Altschuld RA (1970). Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 218, 153-159.
6. Bonne G, Carrier L, Richard P, Hainque B & Schwartz K (1998). Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 83, 580-593.
7. Chandra M, Tschirgi ML & Tardiff JC (2005). Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Am J Physiol Heart Circ Physiol 289, H2112-H2119.
8. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K & Watkins H (2003). Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41, 1776-1782.
9. Elliott K, Watkins H & Redwood CS (2000). Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 275, 22069-22074.
10. Frey N, Brixius K, Schwinger RHG, Benis T, Karpowski A, Lorenzen HP, Luedde M, Katus HA & Franz WM (2006). Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy. J Biol Chem 281, 29575-29582.
11. Gomes AV, Liang J & Potter JD (2005). Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem 280, 30909-30915.
12. Gomes AV & Potter JD (2004). Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Mol Cell Biochem 263, 99-114.
13. 2 consumption-pressure-volume area relation in rabbit and dog. Am J Physiol Heart Circ Physiol 255, H366-H374.
14. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W & Morgan JP (1987). Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61, 70-76.
15. Harris DA & Das AM (1991). Control of mitochondrial ATP synthesis in the heart. Biochem J 280, 561-560.
16. Harrison SM & Bers DM (1989). Influence of temperature on the calcium sensitivity of the myofilaments of skinned ventricular muscle from the rabbit. J Gen Physiol 93, 411-428.
17. Harrison SM & Bers DM (1990). Temperature dependence of myofilament Ca sensitivity of rat, guinea pig, and frog ventricular muscle. Am J Physiol Cell Physiol 258, C274-C281.
18. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD & Allard MF (1996). Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 93, 1549-1555.
19. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE & Robbins J (2000). Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87, 805-811.
20. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97, 2536-2542.
21. i. J Biomech 40, 2044-2052.
22. Keller DI, Coirault C, Rau T, Cheav T, Weyand M, Amann K, Lecarpentier Y, Richard P, Eschenhagen T & Carrier L (2004). Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol 36, 355-362.
23. Kimura A, Harada H, Park J-E, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang T-H, Choo J-A, Chung K-S, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T & Sasazuki T (1997). Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16, 379-382.
24. Kohler J, Chen Y, Brenner B, Gordon AM, Kraft T, Martyn DA, Regnier M, Rivera AJ, Wang C-K & Chase PB (2003). Familial hypertrophic cardiomyopathy mutations in troponin I (K183, G203S, K206Q) enhance filament sliding. Physiol Genomics 14, 117-128.
25. Kruger M, Zittrich S, Redwood C, Blaudeck N, James J, Robbins J, Pfitzer G & Stehle R (2005). Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils. J Physiol 564, 347-357.
26. Lang R, Gomes AV, Zhao J, Housmans PR, Miller T & Potter JD (2002). Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem 277, 11670-11678.
27. Langer GA (1982). Sodium-calcium exchange in the heart. Annu Rev Physiol 44, 435-449.
28. Lee J, Niederer S, Nordsletten D, Le Grice I, Smaill B, Kay D & Smith N (2009). Coupling contraction, excitation, ventricular and coronary blood flow across scale and physics in the heart. Philos Transact A Math Phys Eng Sci 367, 3331-3331.
29. Leong HS, Brownsey RW, Kulpa JE & Allard MF (2003). Glycolysis and pyruvate oxidation in cardiac hypertrophy-Why so unbalanced? Comp Biochem Physiol A Mol Integr Physiol 135, 499-513.
30. 2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents. Am J Physiol Heart Circ Physiol 292, H2854-H2866.
31. Luo R-Y, Liao S, Tao G-Y, Li Y-Y, Zeng S, Li Y-X & Luo Q (2006). Dynamic analysis of optimality in myocardial energy metabolism under normal and ischemic conditions. Mol Syst Biol 2, 2006.0031.
32. Lusis AJ & Weiss JN (2010). Cardiovascular networks: systems-based approaches to cardiovascular disease. Circulation 121, 157-170.
33. Marian AJ & Roberts R (2001). The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33, 655-670.
34. Nakata T, Tanaka S, Hamagami S, Miyamoto K, Oh-hori K & Iimura O (1996). Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP. J Nucl Med 37, 1679-1681.
35. Neely JR & Morgan HE (1974). Relationship Between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36, 413-459.
36. Palsson B (2002). In silico biology through "omics". Nat Biotechnol 20, 649-650.
37. Redwood CS, Moolman-Smook JC & Watkins H (1999). Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44, 20-36.
38. Regnier M, Martin H, Barsotti RJ, Rivera AJ, Martyn DA & Clemmens E (2004). Cross-bridge versus thin filament contributions to the level and rate of force development in cardiac muscle. Biophys J 87, 1815-1824.
39. Rice JJ, Wang F, Bers DM & de Tombe PP (2008). Approximate model of cooperative activation and crossbridge cycling in cardiac muscle using ordinary differential equations. Biophys J 95, 2368-2390.
40. Sambandam N, Lopaschuk GD, Brownsey RW & Allard MF (2002). Energy metabolism in the hypertrophied heart. Heart Fail Rev 7, 161-173.
41. Schoffstall B, Kataoka A, Clark A & Chase PB (2005). Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling. J Pharmacol Exp Ther 312, 12-18.
42. Schonekess BO, Allard MF & Lopaschuk GD (1995). Propionyl-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency. Eur J Pharmacol 286, 155-166.
43. Schonekess BO, Allard MF & Lopaschuk GD (1996). Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts. Am J Physiol Heart Circ Physiol 271, 798-805.
44. +-ATPase in guinea-pig cardiac ventricular muscle. J Physiol 481, 647-662.
45. Stanley WC, Lopaschuk GD, Hall JL & McCormack JG (1997). Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Cardiovasc Res 33, 243-257.
46. Suga H (1979). Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol Heart Circ Physiol 236, H498-H505.
47. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, Sasayama S, Yoshibayashi M, Kamiya T & Konishi J (1996). Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 37, 572-577.
48. Takahashi-Yanaga F, Morimoto S, Harada K, Minakami R, Shiraishi F, Ohta M, Lu QW, Sasaguri T & Ohtsuki I (2001). Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 33, 2095-2107.
49. Wambolt RB, Grist M, Bondy GP & Allard MF (2001). Accelerated glycolysis and greater post-ischemic dysfunction in hypertrophied rat hearts are independent of coronary flow. Can J Cardiol 17, 889-894.
50. Watkins H, Ashrafian H & McKenna WJ (2008). The genetics of hypertrophic cardiomyopathy: Teare redux. Heart 94, 1264-1268.
51. Watkins H, Seidman JG & Seidman CE (1995). Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 4, 1721-1727.
52. Wen Y, Pinto JR, Gomes AV, Xu Y, Wang Y, Wang Y, Potter JD & Kerrick WGL (2008). Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice. J Biol Chem 283, 20484-20494.
53. York JW, Penney DG, Weeks TA & Stagno PA (1976). Lactate dehydrogenase changes following several cardiac hypertrophic stresses. J Appl Physiol 40, 923-926.